Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Todd Twiss

Orthopaedic Surgery Joplin, MO Medical Doctor

NPI 1285856955 CMS profile 149076

3105 McClelland Blvd, Joplin, MO 64804

Open in the dashboard

General payments

$91,696

100 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Todd Twiss of Joplin, MO is reported in the CMS Open Payments database as having received $91,696 across 100 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,217 14
2024 General $1,906 10
2023 General $13,494 11
2022 General $17,429 13
2021 General $27,789 19
2020 General $1,488 14
2019 General $19,373 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Todd Twiss
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Todd Twiss were reported at $10,217. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Todd Twiss Orthopaedic Surgery median Middle half National median
2019 $19,373 $644 $140–$2,844 $163
2020 $1,488 $312 $75–$1,860 $114
2021 $27,789 $520 $117–$2,495 $132
2022 $17,429 $598 $128–$2,731 $149
2023 $13,494 $461 $128–$2,264 $160
2024 $1,906 $497 $134–$2,475 $164
2025 $10,217 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Exactech, Inc. $74,899 40 payments
  2. Arthrex, Inc. $13,611 39 payments
  3. Titan Surgical Group, LLC $2,626 14 payments
  4. Stryker Corporation $288 4 payments
  5. Innovation Technologies Inc $150 1 payment
  6. Smith+Nephew, Inc. $106 1 payment
  7. Organogenesis Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $64,350 10 payments
  2. Travel and Lodging $11,037 31 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,500 4 payments
  4. Food and Beverage $5,609 54 payments
  5. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. EQUINOXE Orthopaedic $35,524 19 payments
  2. Equinoxe Orthopaedic $29,178 16 payments
  3. EQUINOXE Orthopaedic $8,608 2 payments
  4. EXACTECHGPS $1,589 3 payments
  5. Irrisept $150 1 payment
  6. NA $149 1 payment
  7. SHOULDER IMPLANTS SPEEDBRIDGE BIO ANCHORS $147 2 payments
  8. AETOS Shoulder System $106 1 payment
  9. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $74 1 payment
  10. INSPACE $65 2 payments
  11. Other $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

261

Median for Orthopedic Surgery: 203

Drug cost

$1,525

Median for Orthopedic Surgery: $1,433

Branded share of claims

26.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 123 $474
Methylprednisolone Generic 51 $359
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 26 $322
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 18 $233
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 25 $118
Amoxicillin Generic 18 $18

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 99 billing codes

Paid by Medicare

$345,303

Medicare's payments for the services billed

Medicare patients

826

Average age 74

Services billed

3,403

492 women, 334 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 34%
Ischemic heart disease 29%
COPD 25%
Depression 25%
Chronic kidney disease 22%
Atrial fibrillation 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

100 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record